Blood First Assay Screening Trial in Treatment-Naïve Patients With Advanced or Metastatic NSCLC
Sign in to PracticeUpdate
Only registered members have full access to PracticeUpdate content.
Additional Info
Blood First Assay Screening Trial (BFAST) in Treatment-Naïve Advanced or Metastatic Non-Small Cell Lung Cancer: Initial Results of the Phase 2 ALK-Positive Cohort
J Thorac Oncol 2021 Jul 23;[EPub Ahead of Print], R Dziadziuszko, T Mok, S Peters, JY Han, J Alatorre-Alexander, N Leighl, V Sriuranpong, M Pérol, G de Castro Junior, E Nadal, F de Marinis, OA Frontera, DSW Tan, DH Lee, HR Kim, M Yan, T Riehl, E Schleifman, SM Paul, S Mocci, R Patel, ZJ Assaf, DS Shames, MS Mathisen, SM GadgeelFrom MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.